The Australian medicinal cannabis industry was established in 2016 following changes to Commonwealth legislation and has since received great interest from agricultural producers, pharmaceutical manufacturers and patients.
However, the industry is still developing and, as such, there are many agricultural producers, pharmaceutical manufacturers, medical practitioners, researchers, and industry representative bodies seeking to understand how the industry might - and should - evolve as it matures.
This report was commissioned by MTPConnect to provide an evidence base to articulate the current size of Australia's medicinal cannabis industry, as well as future estimates for the sector. It aims to serve as a valuable resource to inform policymakers, industry and consumers.
The report was developed in partnership with Deloitte Access Economics and involved consultation with several key stakeholders including the Medicinal Cannabis Industry Australia (MCIA), a variety of medicinal cannabis cultivators and manufacturers, research institutions, patient advocates, medical practitioners and pharmacists.